Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction: A Secondary Analysis From GALACTIC-HF May 15, 2021 Disclosures: TBD
Dr. Douglas Mann and Dr. C. Michael Gibson Discuss: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction: Results Of The LIFE Trial May 15, 2021 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michal Gibson Discuss: Endovascular Ultrasound Renal Denervation To Treat Hypertension Resistant To A Fixed Dose Triple Medication Pill: The Randomized Sham-controlled RADIANCE-HTN TRIO Trial May 15, 2021
Dr. Richard Whitlock and Dr. C. Michael Gibson Discuss: The Left Atrial Appendage Occlusion Study (LAAOS) III May 15, 2021 Disclosures: TBD
Dr. Schuyler Jones, Mr. Greg Merritt, and Dr. C. Michael Gibson Discuss: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial May 15, 2021 Disclosures: TBD
Dr. Eugene Braunwald and Dr. C. Michael Gibson Discuss: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction (paradise-mi) May 15, 2021 Disclosures: TBD
Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss How to Initiate Heart Failure Drugs February 16, 2021 Disclosures: TBA
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss Shockwave FDA Approval February 16, 2021 Disclosures: TBA
Dr. Pierre Amarenco Presents: Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Tia of Atherosclerotic Origin February 10, 2021 Disclosures: TBA
